NOS2 and neoplasm: The marginal increase in NOS2 immunoreactivity in tumor vessel endothelium, along with the increased expression of all three NOS isoforms in other cells in liver, were associated with a significant overexpression of ET-1 immunoreactivity in all tumor tissue cells.